| Physicians’ attitudes toward prescribable mHealth apps and implications for adoption in Germany: mixed methods study F Dahlhausen, M Zinner, L Bieske, JP Ehlers, P Boehme, L Fehring JMIR mHealth and uHealth 9 (11), e33012, 2021 | 107 | 2021 |
| Quantum computing's potential for drug discovery: Early stage industry dynamics M Zinner, F Dahlhausen, P Boehme, J Ehlers, L Bieske, L Fehring Drug Discovery Today 26 (7), 1680-1688, 2021 | 80 | 2021 |
| There's an app for that, but nobody's using it: insights on improving patient access and adherence to digital therapeutics in Germany F Dahlhausen, M Zinner, L Bieske, JP Ehlers, P Boehme, L Fehring Digital health 8, 20552076221104672, 2022 | 65 | 2022 |
| Toward the institutionalization of quantum computing in pharmaceutical research M Zinner, F Dahlhausen, P Boehme, J Ehlers, L Bieske, L Fehring Drug Discovery Today 27 (2), 378-383, 2022 | 40 | 2022 |
| Critical path activities in clinical trial setup and conduct: how to avoid bottlenecks and accelerate clinical trials L Bieske, M Zinner, F Dahlhausen, H Truebel Drug Discovery Today 28 (10), 103733, 2023 | 9 | 2023 |
| Trends, challenges, and success factors in pharmaceutical portfolio management: cognitive biases in decision-making and their mitigating measures L Bieske, M Zinner, F Dahlhausen, H Trübel Drug Discovery Today 28 (10), 103734, 2023 | 8 | 2023 |
| Using Large Language Models for Humanitarian Frontline Negotiation: Opportunities and Considerations Z Ma, N Zhao, L Bieske, B Bullwinkel, Y Zhang, Z Luo, S Li, G Liao, ... arXiv preprint arXiv:2405.20195, 2024 | 1 | 2024 |
| Classical and quantum optimization of quantum processors T Menke Harvard University, 2022 | 1 | 2022 |
| Geely Automobile Holdings: From'Zero'to Chinese Automotive Industry'Hero' S Laouiti, MA Sodar, M Detchusananart, L Bieske Academy of Asian Business Review 4 (2), 105-132, 2018 | 1 | 2018 |
| Engineering Polaritons in Van Der Waals Heterostructures K Chaudhary Harvard University, 2019 | | 2019 |